The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

UAE summons Iranian ambassador, hands protest note
Dubai Police warn of fraudsters targeting sensitive data
UAE and US Presidents discuss Iranian attacks, regional security
Abu Dhabi Crown Prince begins official visit to Ecuador
NCEMA Chairman: UAE will emerge from this phase stronger, more resilient
Air defence interceptions behind loud sounds heard in Dubai
Abu Dhabi confirms comprehensive readiness following emergency meeting
UAE closes Embassy in Tehran, withdraws Ambassador after Iranian attacks
